Vera Therapeutics - Class A (VERA) closed at $30.06 on October 20, 2026, up 3.9% from the previous close, on volume of 1,148,725 shares (30-day average 2,216,664).
Data as of October 20, 2026.
Globe Newswire (Tue, 20-Oct 8:00 AM ET)
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire (Fri, 2-Oct 4:05 PM ET)
Globe Newswire (Fri, 2-Oct 9:24 AM ET)
Globe Newswire (Tue, 15-Sep 6:30 AM ET)
Vera Therapeutics to Participate at Upcoming Investor Conferences
Globe Newswire (Tue, 1-Sep 7:30 AM ET)
Vera Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results
Globe Newswire (Mon, 10-Aug 4:05 PM ET)
Market Chameleon (Thu, 9-Jul 5:42 AM ET)
Market Chameleon (Wed, 7-Jan 3:16 AM ET)
Market Chameleon (Wed, 10-Dec 3:41 AM ET)
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Vera Therapeutics - Class A trades on the NASDAQ stock market under the symbol VERA.
As of October 21, 2026, VERA stock price climbed to $30.53 with 403,972 million shares trading.
VERA has a beta of 0.96, meaning it tends to be less sensitive to market movements. VERA has a correlation of 0.04 to the broad based SPY ETF.
VERA has a market cap of $2.19 billion. This is considered a Mid Cap stock.
In the last 3 years, VERA traded as high as $56.05 and as low as $9.24.
The top ETF exchange traded funds that VERA belongs to (by Net Assets): VTI, XBI, IWM, VXF, IWO.
VERA has underperformed the market in the last year with a return of +1.1%, while the SPY ETF gained +15.8%. In the last 3 month period, VERA fell short of the market, returning -17.5%, while SPY returned +4.0%. However, in the most recent 2 weeks VERA has outperformed the stock market by returning +3.8%, while SPY returned -1.2%.
VERA support price is $28.91 and resistance is $31.21 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VERA shares will trade within this expected range on the day.
